SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Amneal Pharmaceuticals Reports Third-Quarter Revenue of $862.7M

AMRX

Story updates

11:00:48 AM UTC
SquawkNews
Amneal Pharmaceuticals 3Q Loss/Shr 6c >AMRX
11:00:48 AM UTC
SquawkNews
Amneal Pharmaceuticals 3Q Loss $21.7M >AMRX
11:00:50 AM UTC
SquawkNews
Amneal Pharmaceuticals 3Q Adj EPS 26c >AMRX
11:03:18 AM UTC
SquawkNews
AMNEAL PHARMACEUTICALS Q3 REVENUE USD 863 MILLION VS. IBES ESTIMATE USD 815.9 MILLION
11:12:32 AM UTC
SquawkNews
*-- Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Reports Q3 Revenue $862.7M, vs.
11:14:09 AM UTC
SquawkNews
Amneal Q3 revenue beats estimates on affordable medicines growth; outlook raised

Related stories